10,000 Shares in Opthea Limited Unsponsored ADR $OPT Purchased by EP Wealth Advisors LLC

EP Wealth Advisors LLC acquired a new position in Opthea Limited Unsponsored ADR (NASDAQ:OPT) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 10,000 shares of the company’s stock, valued at approximately $34,000.

A number of other large investors have also modified their holdings of the company. Regal Partners Ltd increased its holdings in shares of Opthea by 78.6% in the 1st quarter. Regal Partners Ltd now owns 5,193,688 shares of the company’s stock worth $17,710,000 after acquiring an additional 2,286,285 shares during the period. Citadel Advisors LLC acquired a new stake in shares of Opthea in the 4th quarter worth about $79,000. Finally, OLD Mission Capital LLC increased its holdings in shares of Opthea by 78.7% in the 1st quarter. OLD Mission Capital LLC now owns 19,167 shares of the company’s stock worth $65,000 after acquiring an additional 8,439 shares during the period. Institutional investors and hedge funds own 55.95% of the company’s stock.

Opthea Stock Up 7.2%

OPT stock opened at $3.41 on Thursday. Opthea Limited Unsponsored ADR has a fifty-two week low of $1.79 and a fifty-two week high of $6.30. The firm’s 50-day simple moving average is $3.41 and its 200 day simple moving average is $3.46.

About Opthea

Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.